Arena Pharmaceuticals (ARNA) Reports Q3 EPS Loss of $0.54

October 17, 2007 4:22 PM EDT Send to a Friend

Arena Pharmaceuticals (Nasdaq: ARNA) reported Q3 loss ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Arena Pharmaceuticals (ARNA) Reports Q3 EPS Loss of $0.54

Member Login

Free News Feed